Literature DB >> 3700243

Chemical modification of herbimycin A. Synthesis and in vivo antitumor activities of halogenated and other related derivatives of herbimycin A.

K Shibata, S Satsumabayashi, H Sano, K Komiyama, A Nakagawa, S Omura.   

Abstract

Several halogenated and other related derivatives of herbimycin A have been synthesized and evaluated in vivo for their activities against Ehrlich ascites carcinoma. Some of these derivatives show higher activities than herbimycin A. Among them the derivatives modified at the 4, 5, 6, and 7-positions of the ansa chain showed particularly high activities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700243     DOI: 10.7164/antibiotics.39.415

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

Review 1.  Macrocyclic inhibitors of hsp90.

Authors:  Victoria A Johnson; Erinprit K Singh; Lidia A Nazarova; Leslie D Alexander; Shelli R McAlpine
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

2.  Two herbimycin analogs, 4,5-dihydro-(4S)-4-hydroxyherbimycin B and (15S)-15-hydroxyherbimycin B, from Streptomyces sp. CPCC 200291.

Authors:  Wei Zhao; Bingya Jiang; Linzhuan Wu; Yanni Nan; Jing Cui; Liyan Yu; Yuzhen Wei; Jinghua Li; Guangzhi Shan
Journal:  J Antibiot (Tokyo)       Date:  2015-02-18       Impact factor: 2.649

3.  Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent.

Authors:  J G Supko; R L Hickman; M R Grever; L Malspeis
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.